Omnicell (OMCL) shares added ~5% on Thursday after KeyBanc Capital Markets upgraded the MedTech, citing a "super-cycle" of ...

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”) ...

Investing.com - Benchmark has raised its price target on Omnicell (NASDAQ:OMCL) to $50.00 from $45.00 while maintaining a Buy rating following the company’s unveiling of its new Titan XT enterprise ...

Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise FORT WORTH, Texas, December 08, ...

Earlier this month, Omnicell, Inc. launched Omnicell Titan XT in the United States, an enterprise automated dispensing system powered by its cloud-based, HITRUST-certified OmniSphere platform to unify ...

FORT WORTH, Texas - Omnicell, Inc. (NASDAQ:OMCL) announced Monday the launch of Titan XT, an enterprise version of its automated dispensing systems designed to enhance medication management across ...

Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

Powered by OmniSphere, Titan XT is built to support evolving healthcare needs while delivering greater pharmacy control and nursing confidence for a growing enterprise Omnicell, Inc. (NASDAQ:OMCL), a ...